Results 201 to 210 of about 13,105 (215)

Transcatheter valve‐in‐valve implantation versus surgical redo aortic root replacement in patients with degenerated freestyle aortic bioprosthesis

Catheterization and cardiovascular interventions, 2021
Transcatheter aortic valve‐in‐valve implantation (ViV TAVI) represents a new treatment option for patients with degenerated aortic bioprosthesis. Comparative data to redo surgical aortic valve replacement (redo SAVR) are limited.
Andrijana Vukadinovikj, E. Baumgartner, K. Bohmann, Denise Härter, G. Wimmer‐Greinecker, C. Burgdorf   +5 more
semanticscholar   +1 more source

Prosthetic valve endocarditis after transcatheter or surgical aortic valve replacement with a bioprosthesis: results from the FinnValve Registry.

EuroIntervention, 2019
AIMS The aim of this study was to compare the risk of prosthetic valve endocarditis (PVE) in patients with transcatheter aortic valve replacement (TAVR) or surgical aortic valve replacement (SAVR).
N. Moriyama, T. Laakso, F. Biancari, P. Raivio, Maina P Jalava, J. Jaakkola, S. Dahlbacka, E. Kinnunen, T. Juvonen, A. Husso, M. Niemelä, Tuomas Ahvenvaara, T. Tauriainen, M. Virtanen, P. Maaranen, M. Eskola, S. Rosato, T. Mäkikallio, M. Savontaus, A. Valtola, V. Anttila, J. Airaksinen, M. Laine   +22 more
semanticscholar   +1 more source

Surgical redo versus transseptal or transapical transcatheter mitral valve‐in‐valve implantation for failed mitral valve bioprosthesis

Catheterization and cardiovascular interventions, 2020
Redo surgical mitral valve replacement (SMVR) is the current standard of care for patients with failed bioprosthetic mitral valve (MV). Transcatheter mitral valve‐in‐valve replacement (TMViV) is arising as an alternative to SMVR in high risk patients. We
F. Simonetto, Paola A M Purita, M. Malerba, M. Barbierato, A. Pascotto, D. Mangino, Chiara Zanchettin, G. Tarantini, G. Gerosa, A. D'Onofrio, C. Cernetti, L. Favero, A. Daniotti, G. Minniti, F. Caprioglio, G. Erente, Tommaso Hinna Danesi, A. Frigo, F. Ronco   +18 more
semanticscholar   +1 more source

Fracture of small Mitroflow® aortic bioprosthesis following valve‐in‐valve transcatheter aortic valve replacement with ACURATE neo valve—From bench testing to clinical practice

Catheterization and cardiovascular interventions, 2020
Valve‐in‐valve (ViV) transcatheter procedures have emerged as a feasible, less‐invasive treatment option for bioprosthetic structural valve deterioration.
I. Amat-Santos, H. Gutíerrez, J. Sathananthan, J. Webb   +3 more
semanticscholar   +1 more source

Long-term results and durability of the CoreValve transcatheter aortic bioprosthesis: outcomes beyond five years.

EuroIntervention, 2019
AIMS The aim of this study was to determine the long-term outcomes of high-risk patients who underwent transcatheter aortic valve implantation (TAVI) with the third-generation CoreValve device, according to the 2017 EAPCI/ESC/EACTS definition of valve ...
R. Panico, C. Giannini, M. De Carlo, M. Angelillis, P. Spontoni, A. Pieroni, G. Costa, P. Bertini, F. Guarracino, A. Petronio   +9 more
semanticscholar   +1 more source

Early Concerning Outcomes for the Edwards Inspiris Resilia Bioprosthesis in the Pulmonary Position.

Annals of Thoracic Surgery, 2022
Sameh M. Said, G. Hiremath, V. Aggarwal, J. Bass, Sandeep Sainathan, Mahmoud I. Salem, S. Narasimhan   +6 more
semanticscholar   +1 more source

Midterm outcomes with a sutureless aortic bioprosthesis in a prospective multicenter cohort study.

Journal of Thoracic and Cardiovascular Surgery, 2021
T. Fischlein, B. Meuris, T. Folliguet, K. Hakim‐Meibodi, M. Misfeld, T. Carrel, M. Zembala, E. Cerutti, F. Asch, A. Haverich   +9 more
semanticscholar   +1 more source

Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial

The Lancet, 2019
J. Lanz, Won-Keun Kim, T. Walther, C. Burgdorf, H. Möllmann, A. Linke, S. Redwood, C. Thilo, M. Hilker, M. Joner, H. Thiele, L. Conzelmann, L. Conradi, S. Kerber, G. Schymik, B. Prendergast, O. Husser, S. Stortecky, D. Heg, P. Jüni, S. Windecker, T. Pilgrim   +21 more
semanticscholar   +1 more source

Early and mid-term outcomes after aortic valve replacement using a novel tissue bioprosthesis: a systematic review.

European Journal of Cardio-Thoracic Surgery
D. Sef, M. S. Thet, Tomislav Klokocovnik, S. Luthra   +3 more
semanticscholar   +1 more source

Early Clinical Outcomes After Transcatheter Aortic Valve Replacement Using a Novel Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis Who Are Suboptimal for Surgery: Results of the Evolut R U.S. Study.

JACC: Cardiovascular Interventions, 2017
J. Popma, M. Reardon, K. Khabbaz, J. Harrison, G. Hughes, S. Kodali, I. George, G. Deeb, S. Chetcuti, R. Kipperman, John M Brown, Hongyan Qiao, J. Slater, Mathew R. Williams   +13 more
semanticscholar   +1 more source